These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16489533)

  • 1. COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States).
    Sansbury LB; Millikan RC; Schroeder JC; North KE; Moorman PG; Keku TO; de Cotret AR; Player J; Sandler RS
    Cancer Causes Control; 2006 Apr; 17(3):257-66. PubMed ID: 16489533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.
    Sansbury LB; Millikan RC; Schroeder JC; Moorman PG; North KE; Sandler RS
    Am J Epidemiol; 2005 Sep; 162(6):548-58. PubMed ID: 16093288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.
    Moorman PG; Sesay J; Nwosu V; Kane JG; de Cotret AR; Worley K; Millikan R
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3013-4. PubMed ID: 16365029
    [No Abstract]   [Full Text] [Related]  

  • 4. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.
    Goodman JE; Bowman ED; Chanock SJ; Alberg AJ; Harris CC
    Carcinogenesis; 2004 Dec; 25(12):2467-72. PubMed ID: 15308583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.
    Steck SE; Butler LM; Keku T; Antwi S; Galanko J; Sandler RS; Hu JJ
    Mutat Res; 2014 Apr; 762():24-31. PubMed ID: 24607854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia.
    Lin HJ; Lakkides KM; Keku TO; Reddy ST; Louie AD; Kau IH; Zhou H; Gim JS; Ma HL; Matthies CF; Dai A; Huang HF; Materi AM; Lin JH; Frankl HD; Lee ER; Hardy SI; Herschman HR; Henderson BE; Kolonel LN; Le Marchand L; Garavito RM; Sandler RS; Haile RW; Smith WL
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1305-15. PubMed ID: 12433707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
    Brasky TM; Bonner MR; Moysich KB; Ochs-Balcom HM; Marian C; Ambrosone CB; Nie J; Tao MH; Edge SB; Trevisan M; Shields PG; Freudenheim JL
    Breast Cancer Res Treat; 2011 Feb; 126(1):157-65. PubMed ID: 20676755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
    Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
    Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
    Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
    Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
    Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
    JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States).
    Huang K; Sandler RS; Millikan RC; Schroeder JC; North KE; Hu J
    Cancer Causes Control; 2006 May; 17(4):385-94. PubMed ID: 16596290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans.
    Kim S; Martin C; Galanko J; Woosley JT; Schroeder JC; Keku TO; Satia JA; Halabi S; Sandler RS
    Am J Epidemiol; 2008 Dec; 168(11):1292-300. PubMed ID: 18945689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor 7-like 2 polymorphism and colon cancer.
    Slattery ML; Folsom AR; Wolff R; Herrick J; Caan BJ; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):978-82. PubMed ID: 18398040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study.
    Satia-Abouta J; Galanko JA; Martin CF; Potter JD; Ammerman A; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):747-54. PubMed ID: 12917206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study.
    Satia JA; Tseng M; Galanko JA; Martin C; Sandler RS
    Nutr Cancer; 2009; 61(2):179-93. PubMed ID: 19235034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
    Thompson CL; Plummer SJ; Merkulova A; Cheng I; Tucker TC; Casey G; Li L
    World J Gastroenterol; 2009 May; 15(18):2240-4. PubMed ID: 19437564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
    Shen J; Gammon MD; Terry MB; Teitelbaum SL; Neugut AI; Santella RM
    Breast Cancer Res; 2006; 8(6):R71. PubMed ID: 17181859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
    Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
    Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
    Mahipal A; Anderson KE; Limburg PJ; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.